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Abstract
Background
Vitamin D could be a mediator in the association between tuberculosis (TB) and diabetes
mellitus (DM). A large scale multi-center study confirmed that TB patients with DM had sig-
nificantly lower serum vitamin D level compared with those without DM and reported that
DM was a strong independent risk factor for vitamin D deficiency.
Objectives
This study was undertaken to determine amongst patients with both TB and DM living in dif-
ferent economically defined areas in China: i) their baseline characteristics, ii) their vitamin
D status and iii) whether certain baseline characteristics were associated with vitamin D
deficiency.
Methods
In DM-TB patients consecutively attending seven clinics or hospitals, we measured 25
hydroxycholecalciferol at the time of registration using electrochemiluminescence in a
COBASE 601 Roche analyser by chemiluminescence immunoassay. Data analysis was
performed using chi square test and multivariate logistic regression.
Results
There were 178 DM-TB patients that included 50 from economically well-developed areas,
103 from better-off areas and 25 from a poverty area. Median vitamin D levels in well-devel-
oped, better-off and poverty areas were 11.5ng/ml, 12.2ng/ml and 11.5ng/ml respectively.
Amongst all patients, 149 (84%) had vitamin D deficiency—91 (51%) with vitamin D defi-
ciency (10–19.9 ng/ml) and 58 (33%) with severe deficiency (< 10 ng/ml). There was a
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significantly higher proportion with vitamin D deficiency in the poverty area. The adjusted
odds of vitamin D deficiency (25-(OH)D3 <20 ng/ml) were significantly higher in those with
longer history of DM (P = 0.038) and with HbA1c�10% (P = 0.003).
Conclusion
Over 80% of TB patients with DM in China were vitamin D deficient, with risk factors being
residence in a poverty area, a long duration of DM and uncontrolled DM. TB programme
managers and clinicians need to pay more attention to the vitamin D status of their patients.
Introduction
Diabetes mellitus (DM) is a chronic condition that occurs when the body cannot produce or
effectively utilize insulin, which results in increased levels of glucose in the blood stream
(hyperglycaemia) causing metabolic disorders of many organs over time [1]. During the past
few decades, socio-economic development, urbanization and life style changes have led to
most countries undergoing a significant epidemiological transition, and this has resulted in a
rapidly increasing burden of DM. In 2015, there were an estimated 415 million people living
with DM globally, with numbers set to rise to nearly 650 million by 2040 [1]. DM is associated
with several co-morbidities, one of which is a three times higher risk of developing tuberculo-
sis (TB) compared with the general population [2,3]. In 2012, the population attributable frac-
tion of DM for adult TB cases globally was estimated at 15% with the number of adult TB cases
associated with DM being 1,042,000 [4].
Vitamin D is a secosteroid which is both synthesized in the skin by the action of sunlight
and ingested in the diet. The vitamin is metabolized first in the liver to 25-hydroxycholecalci-
ferol [25-(OH)D3] and then in the kidney to 1,25- dihydroxycholecalciferol [1,25-(OH)2D3],
an immunologically active hormone [5]. In the context of DM and TB, vitamin D may have an
important role. Experimental research has found that vitamin D and its metabolites regulate
the function of pancreatic ß-cells and influence insulin secretion [6]. Vitamin D also plays a
key role in human innate and adaptive immunity [5], and assists mononuclear phagocytes to
suppress the intracellular growth of Mycobacterium tuberculosis (MTB) after initial infection
[7,8]. Recent research has found that persons with type 2 DM with low serum vitamin D levels
have impaired monocyte function and therefore reduced capacity to restrict the intracellular
growth of MTB, and this may be one of the factors linking DM to an increased risk of TB [9].
For several decades, there has been evidence to show that people with vitamin D deficiency
have a significantly higher risk of developing active TB compared with those who have normal
vitamin D levels [7,8,10]. In turn, TB patients in general have also been reported to have a
higher likelihood of vitamin D deficiency compared with normal controls [11,12]. A small
scale study in urban China, using liquid chromatography-tandem mass spectrometry, reported
significant differences in vitamin D levels between patients with TB, patients with TB and pre-
DM and patients with TB and DM [13]. A larger scale multi-center study in both urban and
rural China, using the electrochemiluminescence (ECLIA) method, confirmed these findings
and reported that DM was a strong independent risk factor for vitamin D deficiency [14].
However, there have been no large scale studies looking at associations between vitamin D lev-
els and DM related risk factors in TB patients who have DM in routine programmatic settings.
Such information would be useful to determine who particularly might be at risk of developing
vitamin D deficiency so that this can be prevented or better identified in the future.
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We therefore conducted a study in patients with both DM and TB and aimed to determine
in relation to their economically-defined residence: i) their baseline characteristics, ii) their
vitamin D status and iii) whether certain baseline characteristics were associated with vitamin
D deficiency.
Material and methods
Design and settings
This was a multi-centre cross-sectional study carried out in seven TB clinics and hospitals
within the routine health services in Jilin Province and Beijing, China.
Seven TB clinics and hospitals in both urban and rural areas were selected for this study.
The selection of the clinics and hospitals was based on the broadly defined economic develop-
ment levels of the catchment areas, a sufficient proportion of TB patients with DM, the avail-
ability of essential laboratory facilities and the willingness of the staff to participate in the study
without requirements of additional funding support. We selected Beijing to represent an eco-
nomically well-developed area; Liaoyuan City and Tonghua City as economically better-off
urban areas; Dongfeng County, Meihekou County and Tonghua County as economically bet-
ter-off rural areas; and Daan County as a poverty stricken area.
Diagnosis of TB
All TB patients were diagnosed, registered, and managed according to the guidelines of the
China National TB Control Program; which is in accordance with those recommended by the
World Health Organization (WHO) [15,16].
Diagnosis of DM
The diagnosis of DM was made in accordance with the WHO guidelines [17]. Patients were
diagnosed with DM either as a result of already being diagnosed by a registered medical insti-
tution and documented in the clinic records, or as a result of a fasting blood glucose (FBG)�
7.0 mmol/L being identified at the time of TB registration or at the time of TB diagnosis from
another health facility regardless if they were on treatment for hyperglycaemia.
Patient recruitment
TB patients with DM who were included in this study were those either presenting to TB ser-
vices by themselves with symptoms suggestive of TB or having been referred from other facili-
ties in the same or nearby catchment area. The patients included were�18 years and newly
registered with any type and category of TB but also with DM according to national and inter-
national guidelines. In order to have accurate data on serum vitamin D levels, we excluded the
following persons from the study: a) being positive for human immunodeficiency virus (HIV),
b) pregnant or lactating women, c) having Aspartate aminotransferase (AST) or Alanine ami-
notransferase (ALT)�3 times the upper limit of normal level as hepatic dysfunction may alter
vitamin D metabolism, d) receiving vitamin D or Vitamin D analogues for any reason, e)
receiving corticosteroid treatment for any reason, and f) receiving anti-cancer therapy as
many drugs disturb hepatic function which alter vitamin D metabolism.
Fasting blood glucose (FBG) and glycocylated haemoglobin (HbA1c)
measurement
Venous blood samples were collected for FBG after a minimum of 10 hours overnight fast
before anti-TB treatment commenced. FBG measurements were done in accordance with
Vitamin D status in DM-TB patients in China
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national guidelines which stipulate that a FBG is carried out using a venous plasma and bio-
chemical analyzer with cut-off thresholds based on those recommended by the WHO [17].
Venous blood samples were collected for HbA1c as above, and HbA1c was analysed using the
cation exchange method with a high performance liquid chromatography performed by
G8-TOSOH, Japan [18].
Blood sample collection and vitamin D measurement
Five ml venous blood sample was taken immediately after their TB registration and before
anti-TB treatment was started. All blood samples were taken following an overnight fast of at
least 10 hours. The samples were centrifuged within 2 hours to separate the serum and stored
at -70˚C until vitamin D analysis was undertaken.
25-hydroxycholecalciferol [25-(OH)D3], was measured in the Beijing Hospital laboratory
with the electrochemiluminescence (ECLIA) method that determines serum 25-(OH)D3 levels
in a COBASE 601 Roche analyser using a chemiluminescence immunoassay (CLIA). Reagents
were supplied by Roche (Switzerland) with a normal measurement range of 3–70 ng/ml. Vita-
min D levels were classified according to the standard definitions of vitamin D status: 25-(OH)
D3� 30 ng/ml = normal; 25-(OH)D3 between 20–29.9 ng/ml = insufficient vitamin D; 25-
(OH)D3 between 10–19.9 ng/ml = vitamin D deficiency; 25-(OH)D3 between 0–9.9 ng/
ml = severe vitamin D deficiency.8
Data collection and analysis
Individual patient data on demographic characteristics, TB symptoms, TB treatment history,
complications, cigarette smoking status and DM related characteristics were collected. The
data were entered to a MS Office Excel (Microsoft, Redmond, WA, USA) datasheet without
patient names and other personal identifiers by the principal investigator and analysed using
SPSS software for Windows, version 13 (SPSS Inc., Chicago, IL, USA). Shapiro-Wilk Test was
used to examine normality distribution of vitamin D values. Nonparametric tests were used to
compare median levels of vitamin D [25-(OH)D3] between groups. Categorical comparisons
of various 25-(OH)D3 levels between DM-TB patients living in different economic areas were
carried out using the chi square test. All P values are 2-tailed. Relationships between 25-(OH)
D3 and baseline exposure variables were evaluated with odds ratios (OR) and 95% confidence
intervals using logistic regression. Levels of significance were set at 5%. Variables with unad-
justed ORs for which the P value was<0.05 were included in a multivariate logistic regression
model.
Ethics approval
The research proposal was approved by the health authorities in the implementing sites. The
Ethics Advisory Group, International Union Against Tuberculosis and Lung Disease, Paris,
France, formally approved this study (EAG number: 102/15). Patients recruited to this study
were informed and agreed to participate. The Union model of Informed Consent Forms was
used and signed by the patients.
Results
There were 178 TB patients with DM consecutively registered in this study. They were 129
males (72%) and 49 females (28%). Of these, 50 were from the economically well-developed
area, 103 from the economically better-off urban and rural areas and 25 from the poverty area.
Vitamin D status in DM-TB patients in China
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The mean age was 56 years (Range 25–89). Patients comprised 73 with smear-positive pulmo-
nary TB, 92 with smear-negative pulmonary TB and 13 with extra pulmonary TB (EPTB).
Baseline characteristics in relation to the type of economical area that the patients resided
in are shown in Table 1. Between the different economically affected areas, there were no sig-
nificant differences in patient characteristics with regards to age, gender, category of TB (new
and previously treated), DM history and level of HbA1c. However, there were some significant
differences in relation to urban / rural residency and type of TB. To further understand the sig-
nificant differences among the three economic areas, we performed a post-test and the results
are shown in Table 2 and Table 3. There were higher proportions of patients with urban resi-
dence and confirmed smear-positive pulmonary TB in the well-developed areas compared
with better-off areas and the poverty area. However, there were no significant differences
between patients from better-off areas and the poverty area.
Amongst all the patients, 149 (84%) had vitamin D deficiency—91 (51%) with vitamin D
deficiency (10–19.9 ng/ml) and 58 (33%) with severe deficiency (< 10 ng/ml). Serum Vitamin
D [25-(OH)D3] levels and proportions of patients with various grades of vitamin D deficiency
in relation to where they lived in terms of economically developed / poor areas are shown in
Table 4. The median level (and IQR) of serum vitamin D among the 3 different economic
areas was similar, but there were significantly higher proportions of patients with vitamin D
deficiency or severe deficiency in the poverty area. Of the TB patients, there were 59 who were
newly diagnosed with DM at the time of TB registration and their characteristics and vitamin
D status are shown in Table 5. They were predominantly male, aged 50 years and above and
more resided in rural areas, and there was a high degree of deficiency or severe deficiency of
vitamin D.
Table 1. Baseline characteristics of patient s with tuberculosis (TB) and diabetes mellitus (DM) in China.
Characteristics Number (%) of the patients residing in different economic areas χ2 P value
Well developed (N = 50) Better-off (N = 103) Poverty (N = 25)
Gender Male 40(31.0) 73(56.6) 16(12.4) 2.452 0.294
Female 10(20.4) 30(61.2) 9(18.4)
Age <50 17(29.3) 33(56.9) 8(13.8) 0.063 0.969
�50 33(27.5) 70(58.3) 17(14.2)
Residence Urban 35(39.3) 44(49.4) 10(11.3) 11.184 0.004
Rural 15(16.9) 59(66.2) 15(16.9)
Type/Sputum smear Positive 36(49.3) 25(34.2) 12(16.5) 39.140 <0.001
Negative 9(9.8) 70(76.1) 13(14.1)
EPTB 5(38.5) 8(61.5) 0
Category of TB New 34(26.8) 74(58.2) 19(15.0) 0.551 0.759
Retreatment 16(31.4) 29(56.9) 6(11.7)
Smoking No 23(28.0) 47(57.3) 12(14.7) 0.046 0.977
Yes 27(28.1) 56(58.3) 13(13.6)
History of DM < 10 years 19(26.8) 38(53.5) 14(19.7) 7.463 0.113
�10 years 18(37.5) 24(50.0) 6(12.5)
undiagnosed 13(22.0) 41(69.5) 5(8.5)
HbA1c <7.0% 10(29.4) 21(61.8) 3(8.8) 1.100 0.902
7.0–9.9% 18(26.5) 40(58.8) 10(14.7)
�10% 22(28.9) 42(55.3) 12(15.8)
TB = tuberculosis; DM = diabetes mellitus
https://doi.org/10.1371/journal.pone.0206372.t001
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Baseline characteristics of TB patients with DM in relation to being vitamin D deficient
(25-(OH)D3 <20ng/ml) are shown in Table 6. The adjusted odds of a TB patient with DM
having vitamin D deficiency were significantly higher in those with a longer history of DM
and in those with uncontrolled DM whose HbA1c�10%. Other baseline characteristics such
as type and category of TB, seasons of TB notification, DM treatment, FBG levels and smoking
status were not associated with vitamin D status.
Discussion
This study aimed to obtain a better understanding of vitamin D status amongst TB patients
with DM in the routine programme setting in China based on their residence according to
economic development and baseline characteristics. There were some interesting findings.
First, there was a low median level of vitamin D in patients with dual disease, which was
lower than levels found previously in non-DM patients with TB and in the general population
[14,19]. This finding is also in line with previous research findings [10,12,13]. Both DM and
TB are diseases that impact on nutritional intake and both may contribute to a lower serum
vitamin D level [5,6]. A recent meta-analysis also confirmed a significantly lower serum vita-
min D level in TB patients versus normal controls, but pointed out a weak association of this
trend for Asian populations [12]. However, this was not observed in our study, and possible
reasons include the poor population and accumulated risk of TB and DM [20]. A study in
India found that no major differences in mean vitamin D levels between TB patients with DM
and without DM, but the proportion of those with severe vitamin D deficiency was higher in
patients with both TB and DM [21].
Second, about one third of all the patients regardless of their residential areas had severe
vitamin D deficiency (<10ng/ml), and this in its own right requires urgent attention. Previous
research has indicated that rifampicin causes an accelerated loss of vitamin D due to increased
body clearance and limited formation of the active form of vitamin D [25-(OH)D3 ] [22]. Iso-
niazid can also cause impairment of 25-hydroxylation leading to impaired immunological
function [23]. Serum vitamin D levels might also be further depressed due to enhanced nega-
tive impacts when the drugs are used in combination. Naik et al observed that the mean vita-
min D level decreased 16% from the time of TB diagnosis to completion of anti-TB treatment
six months later [24]. These findings suggest that there may be a need for vitamin D supple-
mentation in those found with severe vitamin D deficiency at the time of TB registration
Table 2. A post-test: Comparison of the number of patients living in different communities in relation to differ-
ent economic areas.
Comparison group χ2 P value
Well-developed VS better-off area 10.032 0.002
Well-developed VS poverty area 6.250 0.012
Better-off area VS poverty area 0.061 0.805
https://doi.org/10.1371/journal.pone.0206372.t002
Table 3. A post-test: Comparison of the number of patients with different types/smear results in relation to dif-
ferent economic areas.
Comparison group χ2 P value
Well-developed VS better-off area 36.885 <0.001
Well-developed VS poverty area 9.728 0.006
Better-off area VS poverty area 5.860 0.044
https://doi.org/10.1371/journal.pone.0206372.t003
Vitamin D status in DM-TB patients in China
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[25,26]. However, further research is required in this area, as there are conflicting reports
about this aspect [11,27,28].
Third, a literature review has shown that there are low serum vitamin D levels among per-
sons living in poor areas compared with developed areas [29], similar to our findings in this
study. In the poverty county defined by the China State Council, there was a significantly
higher proportion of DM-TB patients with vitamin D deficiency compared with patients in
the other economic areas. China is a country with high incidence of TB and high prevalence of
latent TB infection [30]. A recent meta-analysis confirmed that vitamin D deficiency is
strongly associated with an increased risk of progression from latent TB infection to active TB
disease with or without household contacts [12]. This raises the question about whether there
is a need for early interventions focused on improving nutritional intake and food fortification
with vitamin D supplements and requires discussion amongst policy makers.
Fourth, we did not find associations between vitamin D deficiency and baseline characteris-
tics such as age, gender, residential community and number of daily cigarettes smoked, find-
ings also in line with previous research [14]. Contrary to previous research [14,28], we found
no strong association in this study with season, possibly because most of our patients lived in
urban areas which may not have been so affected by reduced nutritional intake that occurs in
the winter time. In the previous report, 32.5% of the study population resided in urban areas,
but the figure was 50.0% in the current study. Another intriguing finding that also requires
Table 4. Vitamin D status in TB patients with DM, stratified by their residence in different economic areas in China.
Vitamin D status Patients in well- developed area
N = 50
Patients in better-off area
N = 103
Patients in poverty area
N = 25
P value
Median level (ng/ml) (IQR) 11.5 (7.08, 15.65) 12.2 (8.80, 17.80) 11.5 (9.95, 14.55) 0.387
No (%) with normal level
(�30ng/ml)
2 (4.0) 3 (2.9) 0 (0) 0.655
No (%) with insufficiency
(20–29.9ng/ml)
6 (12.0) 17 (16.5) 1 (4.0) <0.001
No (%) with deficiency
(10–19.9ng/ml)
22 (44.0) 51 (49.5) 18 (72.0) <0.001
No (%) with severe deficiency
(<10ng/ml)
20 (40.0) 32 (31.1) 6 (24.0) <0.001
Vitamin D status determined by measurements of 25-(OH)D3. DM = Diabetes mellitus; TB = Tuberculosis; IQR = interquartile range
https://doi.org/10.1371/journal.pone.0206372.t004
Table 5. Characteristics of TB patients newly diagnosed with DM at the time of TB registration in China.
Characteristics/Categories Number (%) of distributions
Gender Male 40 (67.8)
Female 19 (32.2)
Residence Urban 24 (40.7)
Rural 35 (59.3)
Age <50 years 16 (27.1)
�50 years 43 (72.9)
Smoking Yes 30 (50.9)
No 29 (49.1)
Serum vitamin D level Normal�30ng/ml 3 (5.1)
Insufficiency 20–29.9ng/ml 5 (8.5)
Deficiency 10–19.9ng/ml 30 (50.8)
Severe deficiency <10ng/ml 21 (35.6)
https://doi.org/10.1371/journal.pone.0206372.t005
Vitamin D status in DM-TB patients in China
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further research was that patients with smear-positive pulmonary TB were not at increased
risk of vitamin D deficiency compared with those who had smear-negative disease. This
appears to be counter-intuitive as smear-positive TB tends to be associated with increased dis-
ease severity or long-term illness [31], which in turn might be expected to increase the risk of
vitamin D deficiency.
Having a history of DM for 10 years or more or a serum glycosylated haemoglobin
(HbA1c) level�10% were independent risk factors for vitamin D deficiency. Reasons may be
as follows. Both DM and TB are associated with malnutrition and this association may be
stronger with a longer duration of DM and multiple episodes of TB [32]. Amongst our study
group, the proportion with older age and retreatment TB at nearly 30% was higher than found
in a previous study of TB patients [14], a finding similar to that observed in Guangzhou [33].
HbA1c reflects average blood glucose levels over a period of 2–3 months and may be less
affected by infection related hyperglycaemia [34]. HbA1c�10% represents poor glycaemic
control and is an indicator for administering insulin treatment in DM patients with TB as rec-
ommended by the Union and World Diabetes Foundation. A recent systematic review
Table 6. Baseline characteristics in TB patients with DM in relation to vitamin D deficiency (<20ng/ml).
Characteristics Total
(N = 178)
No. (%) with vitamin D deficiency
(N = 149)
Univariate OR (95%
CI)
Multivariate OR (95%
CI)
P value
Gender Male 129 108 (83.7) Reference
Female 49 41 (83.7) 1.00 (0.41–2.43)
Age <50 years 58 48 (82.8) Reference
�50 years 120 101 (84.2) 1.11 (0.48–2.56)
Residence Urban 89 76 (85.4) Reference
Rural 89 73 (82.0) 0.78 (0.35–1.74)
Type/sputum smear Negative 92 77 (83.7) Reference
Positive 73 61 (83.6) 0.99 (0.43–2.27)
EPTB 13 11 (84.6) 1.07 (0.22–5.33)
Category of TB New 127 107 (84.3) Reference
Retreatment 51 42 (82.4) 0.87 (0.37–2.07)
Smoking No 82 69 (84.1) Reference
Yes 96 80 (83.3) 0.94 (0.42–2.10)
Months of TB
registration
May-Oct. 41 33 (80.5) Reference
Nov.-Apr. 137 116 (84.7) 1.34 (0.54–3.30)
DM history <10 years 71 54 (76.1) Reference
�10 years 48 44 (91.7) 3.46 (1.09–11.04) 3.57 (1.07–11.83) 0.038
Undiagnosed 59 51 (86.4) 2.01 (0.80–5.05) 2.57 (0.96–6.90) 0.062
DM treatment Yes 117 97 (82.9) Reference
No 61 52 (85.2) 1.19 (0.51–2.80)
FBG control �7.0 mmol/L 9 7 (77.8) Reference
7.1–9.9 mmol/L 79 62 (78.5) 1.04 (0.20–5.48)
10.0–11.9 mmol/
L
33 29 (87.9) 2.07 (0.31–13.68)
�12 mmol/L 57 51 (89.5) 2.43 (0.41–14.47)
HbA1c level <7.0% 34 25 (73.5) Reference
7.0–9.9% 68 52 (76.5) 1.17 (0.45–3.01) 1.23 (0.45–3.36) 0.683
�10.0% 76 72 (94.5) 6.48 (1.83–22.91) 7.31 (1.97–27.18) 0.003
TB = tuberculosis; EPTB = extra-pulmonary tuberculosis; DM = Diabetes mellitus; OR = odds ratio; CI = confidence interval
https://doi.org/10.1371/journal.pone.0206372.t006
Vitamin D status in DM-TB patients in China
PLOS ONE | https://doi.org/10.1371/journal.pone.0206372 November 1, 2018 8 / 12
highlighted that HbA1c is a reliable risk factor of all-cause mortality and cardiovascular mor-
tality in both DM and non-DM populations [35]. In patients with DM, the risk of all-cause
mortality increased when HbA1c levels were above 8.0% and were highest when levels were
above 9.0% [35]. Our findings and the review suggest that a target value of HbA1c for TB
patients with DM should be set at<8.0% and clinicians need to be made aware of this fact.
Unexpectedly, not being on DM treatment was not associated with vitamin D deficiency. This
finding requires further study, including duration and severity of their diseases.
The strengths of this study were multi-center participation and the large number of TB patients
with DM consecutively enrolled from routine programme settings to avoid selection bias. Vitamin
D status was assessed according to their different economic development areas. To our knowledge,
this is the first report on vitamin D status in DM-TB patients from the routine programme setting
stratified by economic areas in China. There were, however, some limitations. First, for those
patients newly diagnosed with DM, the diagnosis was based on FBG�7.0 mmol/L at the time of
TB notification without validation by other tests such as the oral glucose tolerance test or HbA1c.
Previous research has confirmed the feasibility of taking blood samples for FBG at the time of TB
diagnosis for the majority of TB patients [36], but the use of FBG alone to diagnose DM may under-
estimate the prevalence of DM by as much as 50% [37]. Second, we took blood samples for mea-
surement of HbA1c immediately after the diagnosis of TB without systematically performing a
physical examination. We may therefore have overlooked some conditions that influence the
HbA1c level, such as iron deficiency with or without anaemia [38]. Third, we did not collect data
on history of symptoms or signs of TB, a factor which might have impacted on vitamin D levels,
nor did we analyse patient’s individual food intake in relation to their vitamin D levels. Fourth, the
comparison with some conditions in other published studies may not be a true comparison due to
the lack of a control group. In addition, 25-(OH)D3 was measured with the ECLIA method only in
a COBASE, and results were not confirmed with mass spectrometry, which is more accurate than
the ECLIA method, due to this being unavailable in hospital settings in China.
Conclusions
Our study found that 84% of TB patients with DM had vitamin D deficiency or severe defi-
ciency, with the proportions being higher in patients residing in a designated poverty area
compared with other areas. Those with a longer duration of DM and those showing HbA1c
level�10% were at higher risk of vitamin D deficiency. TB Programme managers and clini-
cians need to pay more attention to vitamin D status in their patients, especially for those in
living in poverty areas.
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